LevelⅢ组淋巴结清扫在乳腺癌改良根治术中的应用价值

朱峰; 李汉城; 刘晓; 崔中华; 朱峰; 李汉城; 刘晓; 崔中华

[1]

Dillon MF,Advani V,Masterson C,et al.The value of level Ⅲ clearance in patients with axillary and sentinel node positive breast cancer[J].Ann Surg,2009,249(5):834.

[2]

马榕,孙靖中,王建丽,等.保留乳头改良根治术治疗乳癌中远期疗效[J].中国实用外科杂志,2003,23(10):606-607.

[3]

陈孝平.外科学[M].北京:人民卫生出版社,2002:429-430.

[4]

陈侃,季巧金,周冠年.乳癌Ⅲ区淋巴结清扫的临床意义[J].中华普通外科杂志,2006,21(10):747-748.

[5]

[6]

Yildirim E,Berberoglu U.Lymph node ratio is more valuable than level Ⅲ involvement for prediction of outcome in node-positivebreast carcinoma patients[J].World J Surg,2007,31(2):276.

[7]

Chen SC,Chang HK,Lin YC,et al.Prognosis of breast cancer after supraclavicular lymph node metastasis:not a distant metastasis[J].Ann Surg Oncol,2006,13(11):1457.

[8]

李树玲.乳腺肿瘤学[M].北京:科学文献技术出版社,2000:391-397.

[9]

Keskek M,Balas S,Gokoz A,et al.Reevaluation of Axillary Skip Metastases in the Era of Sentinel Lymph Node Biopsy in Breast Cancer[J].Surg Today,2006,36(12):1047-1052.

[10]

Boora RS,Bonanni R,Rosato FE.Patterrls of axillary nodal involvement in breast cancer.Predictability of level one dissection[J].Ann Surg,1982,196(6):642-644.

[11]

王晓亮,毛琼儿,蒋友华.122例NDNl浸润性非特殊型乳腺癌的Ⅲ组淋巴结转移预测分析[J].外科理论与实践,2004,9(2):110-112.

[12]

惠锐.乳腺癌腋窝淋巴结转移规律的回顾性分析[J].肿瘤防治杂志,2004,11(9):933-936.

[13]

Blancas I,Garcia-Puche JL,Bermejo B,et al.Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor[J].Ann Oncol,2006,17(11):1644-1649.

[14]

Den BalKker MA.Van Weeszenberg A.De Kanter AY.Non-sentinel lymnh node involvement in patients with breast cancer and sentinel node micrometastasis；too early to abandon axillary clearance[J].J Clin Pathol,2002,55(12):932-935.

[15]

马榕,张小桥,孙靖中.术中淋巴染色对早期乳腺癌前哨淋巴结判定作用研究[J].中国现代普通外科进展,2005,8(1):43-44.